SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Corporate Professionals Capital informs about updates on open offer

24 Sep 2015 Evaluate

Corporate Professionals Capital (‘Manager to the Open Offer’) on behalf of Shivalik Rasayan Limited (‘Acquirer’) along with Growel Capital Services Private Ltd, Bishnoi Exports Private Limited, NIAM International Private Limited, Rahul Bishnoi and Ashwani Kumar Sharma (‘Persons Acting in Concert or PACs’) has informed about this Detailed Public Statement (‘DPS’) for the attention of Equity shareholders of Medicamen Biotech Ltd (‘Target Company’), in compliance with Regulation 13(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendment thereto (if any) (‘SEBI (SAST) Regulations’) pursuant to the Public Announcement (‘PA’) filed on September 16, 2015 with BSE Ltd (‘BSE’), Securities and Exchange Board of India (‘SEBI’) and with Target Company, In terms of Regulation 3(1) and 4 of the SEBI (SAST) Regulations. The details of the Open Offer are acquirer along with PACs made an Open Offer to acquire up to 25,98,338 Equity Shares of the face value Rs 10 each being 26.00% of the of the present Issued, subscribed and paid up equity share capital of the Target Company at a price of Rs 40.00 per fully paid up Equity Share payable in cash, subject to the terms and conditions as set out in PA, this Detailed Public Statement and the Letter of Offer, that will be sent to the shareholders of the Target Company. The Identified Date-October 29, 2015, Offer Opening Date-November 16, 2015, and Offer Closing Date-November 30, 2015

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×